FDMT vs OKE · rev $37.0K vs P/E 15, rev $21.70B
4D Molecular Therapeutics Inc (FDMT) versus ONEOK Inc (OKE) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
ONEOK Inc (OKE) is a oil & gas midstream company listed on NYSE.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
Latest reported OKE revenue for 2024-12-31 was $21.70B. Net income was $3.11B. Revenue was up 22.7% from 2023-12-31 to 2024-12-31. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
FDMT currently screens at market cap $518.1M. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
Not investment advice. Open the FDMT and OKE stock pages for the full models.
Not investment advice.